Approval · Notice of Compliance 13532 · 2012
STRESNIL: Notice of Compliance 13532
Issued July 31, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13532
- Date
- July 31, 2012
- Company
- Elanco Division Eli Lilly Canada IncGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in ownership
- Therapeutic class
- Sedative/Tranquilizer
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| STRESNIL | 00755710 | Marketed |
Medicinal ingredients
- AZAPERONE 40 MG per ML